Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review

Purpose. A case series of icatibant use in intubated patients with angiotensin-converting enzyme inhibitor- (ACEI-) induced angioedema is presented along with a relevant literature review and recommendations for utilization. Summary. Three intubated patients admitted to the intensive care unit for A...

Full description

Saved in:
Bibliographic Details
Main Authors: Erin K. Yeung, Haritha Saikumar, Jose Castaneda-Nerio, Sandra G. Adams, Mark Wong
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Critical Care
Online Access:http://dx.doi.org/10.1155/2018/8081607
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560401264410624
author Erin K. Yeung
Haritha Saikumar
Jose Castaneda-Nerio
Sandra G. Adams
Mark Wong
author_facet Erin K. Yeung
Haritha Saikumar
Jose Castaneda-Nerio
Sandra G. Adams
Mark Wong
author_sort Erin K. Yeung
collection DOAJ
description Purpose. A case series of icatibant use in intubated patients with angiotensin-converting enzyme inhibitor- (ACEI-) induced angioedema is presented along with a relevant literature review and recommendations for utilization. Summary. Three intubated patients admitted to the intensive care unit for ACEI-induced angioedema were treated with icatibant. A literature search identified one controlled study and four case reports describing the use of icatibant in intubated ACEI-induced angioedema patients. Conclusion. Icatibant administration in intubated patients may be beneficial in decreasing time to extubation and length of intensive care unit stay. In the three cases described, icatibant administration did not appear to elicit a response in intubated patients, which has been described in previous case reports. For clinicians considering icatibant in the treatment of ACEI-induced angioedema, earlier administration upon arrival to the ED or immediately upon arriving to the intensive care unit is strongly advised. The suggested benefit of icatibant in intubated ACEI-induced angioedema patients should be verified by randomized clinical trials and cost-benefit analyses should be performed at individual institutions.
format Article
id doaj-art-8938363dcb8d4d54b630bd2d1bb0e664
institution Kabale University
issn 2090-6420
2090-6439
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Critical Care
spelling doaj-art-8938363dcb8d4d54b630bd2d1bb0e6642025-02-03T01:27:40ZengWileyCase Reports in Critical Care2090-64202090-64392018-01-01201810.1155/2018/80816078081607Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature ReviewErin K. Yeung0Haritha Saikumar1Jose Castaneda-Nerio2Sandra G. Adams3Mark Wong4Department of Pharmacy Services, South Texas Veterans Health Care System, 7400 Merton Minter, San Antonio, TX 78229, USAMedicine Service, Pulmonary/Critical Care Division, South Texas Veterans Health Care System, 7400 Merton Minter (111E), San Antonio, TX 78229, USAMedicine Service, Pulmonary/Critical Care Division, South Texas Veterans Health Care System, 7400 Merton Minter (111E), San Antonio, TX 78229, USAMedicine Service, Pulmonary/Critical Care Division, South Texas Veterans Health Care System, 7400 Merton Minter (111E), San Antonio, TX 78229, USADepartment of Pharmacy Services, South Texas Veterans Health Care System, 7400 Merton Minter, San Antonio, TX 78229, USAPurpose. A case series of icatibant use in intubated patients with angiotensin-converting enzyme inhibitor- (ACEI-) induced angioedema is presented along with a relevant literature review and recommendations for utilization. Summary. Three intubated patients admitted to the intensive care unit for ACEI-induced angioedema were treated with icatibant. A literature search identified one controlled study and four case reports describing the use of icatibant in intubated ACEI-induced angioedema patients. Conclusion. Icatibant administration in intubated patients may be beneficial in decreasing time to extubation and length of intensive care unit stay. In the three cases described, icatibant administration did not appear to elicit a response in intubated patients, which has been described in previous case reports. For clinicians considering icatibant in the treatment of ACEI-induced angioedema, earlier administration upon arrival to the ED or immediately upon arriving to the intensive care unit is strongly advised. The suggested benefit of icatibant in intubated ACEI-induced angioedema patients should be verified by randomized clinical trials and cost-benefit analyses should be performed at individual institutions.http://dx.doi.org/10.1155/2018/8081607
spellingShingle Erin K. Yeung
Haritha Saikumar
Jose Castaneda-Nerio
Sandra G. Adams
Mark Wong
Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review
Case Reports in Critical Care
title Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review
title_full Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review
title_fullStr Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review
title_full_unstemmed Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review
title_short Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and Literature Review
title_sort icatibant for angiotensin converting enzyme inhibitor induced angioedema in intubated patients case series and literature review
url http://dx.doi.org/10.1155/2018/8081607
work_keys_str_mv AT erinkyeung icatibantforangiotensinconvertingenzymeinhibitorinducedangioedemainintubatedpatientscaseseriesandliteraturereview
AT harithasaikumar icatibantforangiotensinconvertingenzymeinhibitorinducedangioedemainintubatedpatientscaseseriesandliteraturereview
AT josecastanedanerio icatibantforangiotensinconvertingenzymeinhibitorinducedangioedemainintubatedpatientscaseseriesandliteraturereview
AT sandragadams icatibantforangiotensinconvertingenzymeinhibitorinducedangioedemainintubatedpatientscaseseriesandliteraturereview
AT markwong icatibantforangiotensinconvertingenzymeinhibitorinducedangioedemainintubatedpatientscaseseriesandliteraturereview